Cargando…
Targeting the Proteostasis Network for Mycobacterial Drug Discovery
[Image: see text] Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), remains one of the world’s deadliest infectious diseases and urgently requires new antibiotics to treat drug-resistant strains and to decrease the duration of therapy. During infection, Mtb encounters numerous stresses...
Autores principales: | Lupoli, Tania J., Vaubourgeix, Julien, Burns-Huang, Kristin, Gold, Ben |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2018
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902792/ https://www.ncbi.nlm.nih.gov/pubmed/29465983 http://dx.doi.org/10.1021/acsinfecdis.7b00231 |
Ejemplares similares
-
Targeting the proteostasis network in Huntington’s disease
por: Soares, Tânia R., et al.
Publicado: (2019) -
Mycobacterial drug discovery
por: Abrahams, Katherine A., et al.
Publicado: (2020) -
Mycobacterial genomics and structural bioinformatics: opportunities and challenges in drug discovery
por: Waman, Vaishali P., et al.
Publicado: (2019) -
Dysregulated proteostasis network in neuronal diseases
por: Tseng, Ching-San, et al.
Publicado: (2023) -
Remodeling the endoplasmic reticulum proteostasis network restores proteostasis of pathogenic GABA(A) receptors
por: Fu, Yan-Lin, et al.
Publicado: (2018)